Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis.

被引：0
|
作者：
Grizzi, Giulia
Petrelli, Fausto
Ghidini, Michele
Ghidini, Antonio
Ratti, Margherita
Panni, Stefano
Cabiddu, Mary
Ghilardi, Mara
Borgonovo, Karen
Parati, Maria Chiara
Barni, Sandro
Tomasello, Gianluca
Passalacqua, Rodolfo
Berruti, Alfredo
Brighenti, Matteo
机构：
[1] ASST Cremona, Oncol Dept, Oncol Unit, Cremona, Italy
[2] ASST Bergamo Ovest, Treviglio, Italy
[3] ASST Cremona, Oncol Unit, Cremona, Italy
[4] Osped Cremona, ASST Cremona, Cremona, Italy
[5] Univ Brescia, Spedali Civili Hosp, Med Oncol, Brescia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14130
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis
    Azadeh, Hossein
    Alizadeh-Navaei, Reza
    Rezaiemanesh, Alireza
    Rajabinejad, Misagh
    INFLAMMOPHARMACOLOGY, 2022, 30 (02) : 435 - 451
  • [42] Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
    Xiaoxiang Zhou
    Zhuoran Yao
    Huaxia Yang
    Naixin Liang
    Xuan Zhang
    Fengchun Zhang
    BMC Medicine, 18
  • [43] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [44] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    Current Rheumatology Reports, 2018, 20
  • [45] Risk of Immune-Related Pancreatitis in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors: Systematic Assessment with Meta-Analysis
    Su, Qiang
    Zhang, Xiao-chen
    Zhang, Chen-guang
    Hou, Yan-li
    Yao, Yu-xia
    Cao, Bang-wei
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [46] Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Zhang, Wei
    Tan, Yifei
    Li, Yuquan
    Liu, Jiang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
  • [48] Analysis of immune-related adverse events in gastrointestinal malignancy patients treated with immune checkpoint inhibitors
    Niu, Chengu
    Zhu, Kaiwen
    Zhang, Jing
    Joshi, Utsav
    Liu, Hongli
    Zahid, Salman
    Jadhav, Nagesh
    Okolo, Patrick I.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1261 - 1271
  • [49] Immune-related adverse events of checkpoint inhibitors
    Ramos-Casals, Manuel
    Brahmer, Julie R.
    Callahan, Margaret K.
    Flores-Chavez, Alejandro
    Keegan, Niamh
    Khamashta, Munther A.
    Lambotte, Olivier
    Marlette, Xavier
    Prat, Aleix
    Suarez-Almazor, Maria E.
    NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [50] Immune-related adverse events of checkpoint inhibitors
    Manuel Ramos-Casals
    Julie R. Brahmer
    Margaret K. Callahan
    Alejandra Flores-Chávez
    Niamh Keegan
    Munther A. Khamashta
    Olivier Lambotte
    Xavier Mariette
    Aleix Prat
    Maria E. Suárez-Almazor
    Nature Reviews Disease Primers, 6
12345